Hybridomas

Hybridomas are laboratory-created cell lines composed of fused antibody-producing B cells (B lymphocytes) and myeloma cells, which are cancerous cells of the immune system. They are used to produce large quantities of monoclonal antibodies, which are specialized proteins that recognize and attach to a particular antigen. These antibodies can then be used to detect and measure antigens in diagnostic tests and therapeutic treatments, such as cancer immunotherapies. Hybridomas are important tools in medical research and diagnosis and have made it possible to specifically target malignant cells and treat a variety of diseases.


From: International Journal of Antibiotic Research

Related Article For "Hybridomas"

About (1) results

Editor-in-chief: Mujeeb Ur Rehman Nasar, Huazhong Agricultural University
Publication Type: Open Access Journal
Description: International Journal of Antibiotic Research is an openaccess, peer review journal for original analysis on Antibiotics in different disease conditions. IJANR a multi-disciplinary journal covering the general fields of pharmacology, biochemistry, genetics,and microbiology .